CASI Pharmaceuticals (US: CASI)

Last close As at 27/10/2025

0.00 (0.00%)

Market capitalisation

Edison Investment Research is terminating coverage on CASI Pharmaceuticals. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Latest Insights

View More

Healthcare | Update

CASI Pharmaceuticals — Evomela sales drive guidance upgrade

Healthcare | Update

CASI Pharmaceuticals — Continuing to execute

Healthcare | Update

CASI Pharmaceuticals — Evomela sales going strong into 2021

Thematics